Clinical predictors of hiv infection in hospitalized children aged 2 -18 months in Harare, Zimbabwe

African Health Sciences

Volumn 12, Issue 3, 2012, Pages 259-267

  Nathoo, K J ^a   Rusakaniko, S ^a   Tobaiwa, O ^a   Mujuru, H A ^a   Ticklay, I ^a   Zijenah, L ^a  

^a UNIVERSITY OF ZIMBABWE   (Zimbabwe)

Author keywords

Clinical predictors; HIV; Hospitalized children

Indexed keywords

VIRUS DNA;

ARTICLE; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; CYANOSIS; DIARRHEA; EAR DISEASE; EDEMA; FEMALE; HEPATOMEGALY; HIV TEST; HOSPITALIZED CHILD; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INFANT; INFANT MORTALITY; JAUNDICE; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; MALE; NUTRITIONAL STATUS; PALLOR; PAROTID GLAND DISEASE; PNEUMONIA; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE; PRESCHOOL CHILD; RASH; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; SEX RATIO; SPLENOMEGALY; THRUSH; TUBERCULOSIS; VIRUS DETECTION; VOMITING; WEIGHT REDUCTION; ZIMBABWE;

CLINICAL PREDICTORS; HIV; HOSPITALIZED CHILDREN;

CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HIV-1; HOSPITALIZATION; HUMANS; INFANT; LOGISTIC MODELS; MALE; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE OF TESTS; PREVALENCE; QUESTIONNAIRES; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; ZIMBABWE;

EID: 84872472081     PISSN: 16806905     EISSN: None     Source Type: Journal    
DOI: 10.4314/ahs.v12i3.3     Document Type: Article

References (35)

1. UNAIDS Report on the Global AIDS Epidemic; 2010 www.unaids.org/documents/20101123_epislides_core_en.pdf
2. Newell M-L, Coovadia H, Cortina-Borja M, Rollins N, Gaillard P, Dabis F, for the Ghent International AIDS Society(IAS) working group on HIV infection in women and children. Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis. Lancet 2004;364:1236-43
3. Moodley D, Moodley P, Moodley J et al. Use of rapid tests for perinatal HIV infection in resource limited settings. Journal of Pediatric Infectious Diseases 2006;1:105-110
4. Sherman GG, Cooper PA, Coovadia AH et al. Polymerase Chain Reaction for Diagnosis of Human Immunodeficiency Virus Infection in Infancy in Low Resource Settings. Pediatr Infect Dis J. 2005;24(11):993-996.
5. Creek T, Tanuri A, Smith M. et al. Early Diagnosis of Human Immunodeficiency Virus in infants Using Polymerase Chain Reaction on Dired Blood Spots in Botswana's National Program for Prevention of Mother-to Child Transmission. Pediatr Infect Dis J 2008;27:22-26
6. Sherman GG, Stevens G, Jones SA, Horsfield P, Stevens WS. Dried blood spots improve access to HIV diagnosis and care for infants in low-resource settings. J Acquir Immune defic Syndr. 2005; 38: 615-617
7. Pizzo PA, Wilbert CM. Pediatric Aids. 3rd Ed. Lippincott, Williams and Wilkins 1998.
8. World Health Organization. Antiretoviral Therapy of HIV Infection in Infants and Children in Reource- limited settings: Towards Universal Access. Recommendations for a Public Health Approach. Geneva: World Health Organization;2006.
9. WHO, Report and recommendations of the WHO guideline review meeting to review recommendations on the diagnosis of HIV infection in infants and children. 2008, World Health Organization: Geneva
10. www.who.int/child/growthref/en (WHO/WHO Anthro (version 3.2.2 January 11)
11. World Health Organization, Division of Diarrhoeal and Acute Respiratory Disease Control. Integrated management of the sick child. Bulletin of the World Health Organization 1995;73:735-40.
12. Gove S. Integrated management of childhood illness by outpatient health workers: technical basis and overview. Bulletin of the World Health Organization 1997;75(Suppl 1):7-24
13. Zijenah LS, Humphrey J, Nathoo K et al. Evaluation of the prototype Roche DNA amplification kit incorporating the new SSKI45/ SKCCIB primers in the detection of HIV-1 infection in Zimbabwe. J Clin Microbiol 1999: 37:3569-3571
14. The Zimbabwe Programme for Prevention of Mother to Child transmission of HIV (PMTCT) 2006 Annual Report.
15. Black RE, Morris SS, Bryce J. Where and why are 10 million children dying every year? Lancet 2003;361:2226-2234
16. Multiple Indicator Monitoring Survey (MIMS)2009 Preliminary Report November 2009. Central Statistical Office (CSO) Zimbabwe, with technical and financial support from the United Nations Children's Fund (UNICEF)
17. Spira R, Lepage P, Msellati Pet al. Natural history of human immunodeficiency virus type 1 infection in children: a five-year prospective study in Rwanda. Pediatrics 1999;104:e56.
18. Bobat R, Moodley D, Coutsoudis A, Coovadia H, Gouws E. The early Natural history of vertically transmitted HIV infection in african children in Durban South Africa. Ann Trop Paediatr 1998;18(3) 187-96
19. Bobat R, Coovadia H, Moodley D, Coutsoudis A, Gouws E.Growth in early childhood in a cohort of children born to HIV-1 infected women from Durban, South Africa. Ann Trop Paediatr 2001;21(3) 203-10
20. Moye J, Rich KC, Kalish LA, et al Natural history of somatic growth in infants born to women infected by human immunodeficiency virius. J Pediatr 1996;128(1)658-6
21. Arpadi, S.M. Growth velocity, fat-free mass and energy intake are inversely related to viral load in HIV-infected children. JNutr, 2000;130 (10): 2498-502.
22. Gutman LT, Moye J, Zimmer B, Tian C. Tuberculosis in human immunodeficiency virus-exposed or -infected United States children. Pediatr Infect Dis J 1994;13:963-8.
23. WHO. Global tuberculosis control: a short update to the 2009 report. WHO/HTM/TB/ 2009.426. Accessed at http://www.who.int/tb/publications/global_report/2009/update/en/index.html on June 3, 2010.
24. Coovadia HM, Jeena P, Wilkinson D. Childhood human immunodeficiency virus and tuberculosis co-infections: reconciling conflicting data. Int J Tuber Lung Dis 1998;2:844-51
25. Bakaki P, Kayita J, Moura M et al. Epidemiologic and clinical features of HIV-Infected and HIVUninfected Ugandan Children Younger than 18 months. J Acquir Immune Defic Syndr 2001;28(1):35-42
26. Inwani I, Mbori-Ngacha D, Nduati R et al. Performance of clinical Algorithms for HIV-1 diagnosis and Antiretroviral Initiation Among HIV-1 exposed Children Aged less than 18 months in Kenya. J Acquir Immune Defic Syndr 2009;50(5):492-498
27. Peltier CA, Omes C, Ndimubanzi PC et al. Validation of 2006 WHO Prediction Scores for True HIV Infection in Children less than 18 months with a positive serological HIV test PLoS ONE I www.plosone.org April 2009; 4 (4): e5312
28. Mayaux MJ, Burgard M, Teglas JP, et al. Neonatal characteristics in rapidly progressive perinatally acquired HIV-1 disease. The French Pediatric HIV Infection Study Group. JAMA 1996;275: 606-610.
29. Ruffini DD, Madhi SA, The high burden of Pneumocystis carinii pneumonia in African HIV-1 infected children hospitalized for severe pneumonia. AIDS 2002;16:105-112
30. Madhi SA, Cutland C, Ismail K, O'reilly C, Mancha A, Klugman KP. Ineffectiveness of trimethoprim-sulphamethoxazole prophylaxis and the importance of bacterial and viral coinfections in African Children with Peumocystis carinii pneumonia. Clin Infect Dis 2002;35:1120-1126
31. Nathoo KJ, Gondo M, Gwanzura L, Mhlanga BR, Mavetera T, Mason PR. Fatal Pneumocystis carinii pneumonia in HIV-seropositive infants in Harare, Zimbabwe. Trans R Soc Trop Med Hyg 2001, 95: 37-39, 1-3
32. Violari A, Cotton MF, Gibb DM, et al. Early antiretroviral therapy and mortality among HIVinfected infants. N Engl J Med 2008; 359:2233-44.
33. World Health Organization. Antiretoviral Therapy of HIV Infection in Infants and Children in Reource-limited settings: Towards Universal Access. Recommendations for a Public Health Approach. Geneva: World Health Organization;2010.
34. Rollins N, Mzolo S, Moodley M. et al. Use of rapid tests for perinatal HIV infection in resource -limited settings. Journal of Pediatric Infectious Diseases; 2006 1:105-110
35. Qazi SA, Muhe LM. Integrating HIV management for children into the Integrated Management of Childhood Illness guidelines. Trans R Soc Trop Med Hyg 2006;100(1):10-13.